ARTICLE | Clinical News
Vomeropherin: Began Phase I testing
February 5, 2001 8:00 AM UTC
Pherin Pharmaceuticals Inc., Mountain View, Calif. Product: Vomeropherin Business: Neurological Therapeutic category: Neurotransmission Target: Chemoreceptors on the vomeronasal organ Description: Che...